Bowhead Specialty (BOW) Competitors $36.35 +1.34 (+3.83%) As of 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BOW vs. PLMR, BWIN, FG, GSHD, OSCR, BHF, HGTY, NMIH, ALHC, and CSShould you be buying Bowhead Specialty stock or one of its competitors? The main competitors of Bowhead Specialty include Palomar (PLMR), The Baldwin Insurance Group (BWIN), F&G Annuities & Life (FG), Goosehead Insurance (GSHD), Oscar Health (OSCR), Brighthouse Financial (BHF), Hagerty (HGTY), NMI (NMIH), Alignment Healthcare (ALHC), and Credit Suisse Group (CS). These companies are all part of the "insurance" industry. Bowhead Specialty vs. Its Competitors Palomar The Baldwin Insurance Group F&G Annuities & Life Goosehead Insurance Oscar Health Brighthouse Financial Hagerty NMI Alignment Healthcare Credit Suisse Group Bowhead Specialty (NYSE:BOW) and Palomar (NASDAQ:PLMR) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, community ranking, media sentiment, analyst recommendations and dividends. Does the media favor BOW or PLMR? In the previous week, Palomar had 13 more articles in the media than Bowhead Specialty. MarketBeat recorded 17 mentions for Palomar and 4 mentions for Bowhead Specialty. Palomar's average media sentiment score of 1.08 beat Bowhead Specialty's score of 0.28 indicating that Palomar is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bowhead Specialty 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Palomar 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is BOW or PLMR more profitable? Palomar has a net margin of 21.23% compared to Bowhead Specialty's net margin of 0.00%. Palomar's return on equity of 19.76% beat Bowhead Specialty's return on equity.Company Net Margins Return on Equity Return on Assets Bowhead SpecialtyN/A N/A N/A Palomar 21.23%19.76%5.78% Do insiders and institutionals hold more shares of BOW or PLMR? 90.3% of Palomar shares are held by institutional investors. 3.7% of Palomar shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts prefer BOW or PLMR? Bowhead Specialty currently has a consensus target price of $39.67, suggesting a potential upside of 9.12%. Palomar has a consensus target price of $164.33, suggesting a potential upside of 2.03%. Given Bowhead Specialty's higher possible upside, analysts plainly believe Bowhead Specialty is more favorable than Palomar.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bowhead Specialty 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.67Palomar 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.71 Which has preferable earnings and valuation, BOW or PLMR? Palomar has higher revenue and earnings than Bowhead Specialty. Bowhead Specialty is trading at a lower price-to-earnings ratio than Palomar, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBowhead Specialty$457.72M2.59$42.79M$1.3127.75Palomar$609.96M7.06$117.57M$5.0132.15 Does the MarketBeat Community prefer BOW or PLMR? Palomar received 83 more outperform votes than Bowhead Specialty when rated by MarketBeat users. Likewise, 61.69% of users gave Palomar an outperform vote while only 57.14% of users gave Bowhead Specialty an outperform vote. CompanyUnderperformOutperformBowhead SpecialtyOutperform Votes1257.14% Underperform Votes942.86% PalomarOutperform Votes9561.69% Underperform Votes5938.31% SummaryPalomar beats Bowhead Specialty on 16 of the 17 factors compared between the two stocks. Get Bowhead Specialty News Delivered to You Automatically Sign up to receive the latest news and ratings for BOW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BOW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BOW vs. The Competition Export to ExcelMetricBowhead SpecialtyFire, marine, & casualty insurance IndustryFinance SectorNYSE ExchangeMarket Cap$1.19B$46.33B$11.73B$19.87BDividend YieldN/A2.19%5.66%3.83%P/E Ratio27.7512.1823.0535.60Price / Sales2.596.9526.8643.81Price / CashN/A16.8117.6017.51Price / BookN/A2.502.894.85Net Income$42.79M$4.16B$1.04B$1.02B7 Day Performance0.89%0.67%1.53%1.94%1 Month Performance-6.12%2.06%1.45%3.02%1 Year Performance38.06%29.79%540.37%9.87% Bowhead Specialty Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BOWBowhead Specialty2.5369 of 5 stars$36.35+3.8%$39.67+9.1%+35.0%$1.19B$457.72M27.75193PLMRPalomar2.7318 of 5 stars$175.67+2.4%$164.33-6.5%+88.8%$4.70B$609.96M39.21150Positive NewsAnalyst RevisionBWINThe Baldwin Insurance Group2.6258 of 5 stars$38.70+0.4%$45.33+17.1%+16.2%$4.59B$1.41B-60.474,000Insider TradeFGF&G Annuities & Life4.2483 of 5 stars$32.25+0.9%$44.33+37.5%-15.6%$4.35B$4.76B6.651,165News CoveragePositive NewsGSHDGoosehead Insurance3.6986 of 5 stars$111.55+3.0%$115.40+3.5%+84.4%$4.19B$325.63M154.931,430Positive NewsOSCROscar Health2.0044 of 5 stars$14.27+3.4%$18.50+29.7%-29.4%$3.63B$10.08B-712.892,710Analyst ForecastHigh Trading VolumeBHFBrighthouse Financial4.4545 of 5 stars$59.13-1.1%$60.80+2.8%+36.0%$3.39B$6.69B11.461,500Positive NewsHGTYHagerty1.7446 of 5 stars$9.91+2.0%$10.50+5.9%-4.5%$3.39B$1.25B90.121,670Insider TradeNMIHNMI2.6078 of 5 stars$39.61-0.3%$42.29+6.8%+27.0%$3.09B$667.96M8.94234ALHCAlignment Healthcare1.4245 of 5 stars$15.51+0.9%$17.17+10.7%+86.9%$3.07B$3.00B-20.14850CSCredit Suisse GroupN/A$0.89flatN/AN/A$2.77B$22.88B1.3750,480 Related Companies and Tools Related Companies Palomar Alternatives The Baldwin Insurance Group Alternatives F&G Annuities & Life Alternatives Goosehead Insurance Alternatives Oscar Health Alternatives Brighthouse Financial Alternatives Hagerty Alternatives NMI Alternatives Alignment Healthcare Alternatives Credit Suisse Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BOW) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bowhead Specialty Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bowhead Specialty With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.